1887

n Cardiovascular Journal of South Africa - Moxonidine suitable for hypertensive menopausal women with metabolic syndrome : drug trends in cardiology

USD

 

Abstract

Extracted from text ... 186 CARDIOVASCULAR JOURNAL OF SOUTH AFRICA Vol 16, No. 3, May/June 2005 Menopause acts specifically as a cardiovascular risk factor by reducing the direct beneficial effect of ovarian hormones, and indirectly by negatively influencing other risk factors for coronary artery disease - hyperinsulinaemia, blood cholesterol, blood pressure, coagulation, obesity and body fat distribution (Table I).1 The treatment of menopausal women with hypertension must take cognisance of the altered metabolic profile of these patients. In these circumstances, centrally acting agents that modulate sympathetic activity offer benefits because of their additional effect on sympathetic tone, glucose and lipid metabolism. Centrally acting agents reduce ..

Loading

Article metrics loading...

/content/cardio/16/3/EJC23991
2005-05-01
2016-12-04
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error